PMID: 9448208Feb 3, 1998Paper

Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children

Journal of the American Academy of Dermatology
S AlaitiI Bekersky

Abstract

Tacrolimus is a potent immunosuppressant used in organ transplant recipients; an ointment formulation is being developed as a therapeutic agent for atopic dermatitis. Our purpose was to define the pharmacokinetics and evaluate tacrolimus 0.3% ointment as therapy for moderate to severe atopic dermatitis. Thirty-nine patients, 5 to 75 years of age, received 14 applications over 8 days. Serial blood samples were collected on days 1 and 8, with predose samples collected on days 2 through 7. Overall response and signs/symptoms were rated daily on days 1 through 11. Incidence of adverse events and laboratory profile were determined. Mean area under the curve (0.9 to 42.5 ng x hr/ml) was highly variable and appeared to be related to size of application area. No systemic accumulation of tacrolimus was observed. Comparison to historical intravenous data indicates that absolute bioavailability of topical tacrolimus was less than 0.5%. Ninety-five percent of patients showed at least good improvement. All adverse events were transient. Burning was the most common application site adverse event and vasodilatation ("flushing/warmth") was the most common nonapplication site adverse event. No drug-related changes in laboratory profile were obs...Continue Reading

References

Jan 1, 1994·Dermatology : International Journal for Clinical and Investigative Dermatology·A I Lauerma, H I Maibach
Sep 1, 1995·The British Journal of Dermatology·H AoyamaH Tagami
Dec 1, 1995·Therapeutic Drug Monitoring·P McMasterA D Mayer
Jul 1, 1996·Dermatologic Clinics·R Graham-Brown
Feb 1, 1996·Pediatric Annals·A R Halbert
Mar 1, 1997·Journal of the American Academy of Dermatology·J ShupackJ E Birnbaum

❮ Previous
Next ❯

Citations

Jun 24, 2009·Archives of Dermatological Research·L J LubakiM Heenen
Aug 11, 2005·Journal of Cutaneous Medicine and Surgery·Jerry Tan, Richard Langley
Nov 13, 2008·International Journal of Hematology·Akane KunitomiHiroshi Sao
Aug 16, 2000·Pediatric Clinics of North America·L Kristal, P A Klein
May 30, 2001·Transplantation Proceedings·A Wollenberg, T Bieber
Sep 13, 2001·Veterinary Immunology and Immunopathology·R Marsella, T Olivry
Jun 5, 2003·Clinics in Dermatology·Nordwig S Tomi, Thomas A Luger
Oct 24, 2003·Clinics in Dermatology·Nelly Rubeiz, Abdul Ghani Kibbi
Mar 3, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Curtis L HedbergSami L Bahna
Nov 3, 2009·Bone Marrow Transplantation·H MawardiN Treister
Jun 9, 2000·Clinical and Experimental Dermatology·I S Nasr
May 1, 2001·International Journal of Dermatology·G G Russo, C Mullen
Dec 12, 2001·Journal of Pediatric Gastroenterology and Nutrition·T HodgsonS Porter
Jun 7, 2002·Journal of Pediatric Gastroenterology and Nutrition·Roy M KimbleGeoff Cleghorn
Aug 4, 2010·Pediatric Dermatology·Alexandra D McCollumLawrence F Eichenfield
Mar 24, 2000·BMJ : British Medical Journal·P A Foley
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Jonathan M Spergel
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Antonello BaldoLuisa Di Costanzo
Aug 23, 2002·Clinical Pharmacokinetics·Uwe ChristiansAlfonso Lampen
Nov 13, 2004·Drugs·Thomas Christian RoosHarald Brost
Apr 1, 2005·American Journal of Clinical Dermatology·Kristine BreuerAlexander Kapp
Nov 12, 2010·American Journal of Clinical Dermatology·Manjunatha Kalavala, Magdalene A Dohil
Jan 25, 2014·International Journal of Pharmaceutics·Masayuki YamanakaShigeru Itai
Sep 12, 1998·Lancet·D Rudikoff, M Lebwohl
Jan 20, 2010·Clinics in Dermatology·Diamant Thaçi, Rebekka Salgo
Apr 2, 2009·International Journal of Dermatology·Sakari ReitamoNasrullah Undre
Dec 16, 2006·The Journal of Dermatology·Masayoshi SuganoAkimichi Morita
Sep 15, 2007·The British Journal of Dermatology·M H A Rustin
Jul 22, 2008·The British Journal of Dermatology·S ReitamoUNKNOWN 0.1% Tacrolimus Ointment Long-term Follow-up Study Group
Oct 4, 2007·International Journal of Dermatology·Tae Young YoonMi Kyeong Kim
May 13, 2014·Journal of the American Academy of Dermatology·Lawrence F EichenfieldRobert Sidbury
Jan 17, 2007·The British Journal of Dermatology·J CallenB U Wintroub
Oct 5, 2001·Expert Opinion on Pharmacotherapy·T AssmannT Ruzicka
Nov 4, 2000·Expert Opinion on Investigational Drugs·J B Travers
Oct 6, 2004·Expert Opinion on Pharmacotherapy·Christie L Carroll, Alan B Fleischer
Mar 1, 2012·Allergology International : Official Journal of the Japanese Society of Allergology·Nobuyuki EbiharaDai Miyazaki
Jan 5, 2002·Seminars in Cutaneous Medicine and Surgery·N RobinsonK B Gordon
Dec 6, 2005·Clinics in Dermatology·Sharareh Ahmadi, Frank C Powell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.